Mediclinic International plc
MEI
Rang in Aktien
#4308
Mediclinic International plc is a prominent healthcare provider that, through... Mediclinic International plc is a prominent healthcare provider that, through its various subsidiaries, manages and operates private hospital facilities. Operating under its well-known Mediclinic and Hirslanden brands, the firm delivers a broad spectrum of specialized and comprehensive healthcare services. Its extensive global network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. This network comprises 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, and 2 mental health facilities, which collectively feature 453 operating theatres and approximately 11,538 inpatient beds. Beyond direct patient care, Mediclinic also offers a range of auxiliary and support services, including treasury functions, medical equipment sourcing and procurement, emergency medical response, general management, food and catering, healthcare administration, and debt recovery. Furthermore, the company handles the management of its healthcare personnel and maintains its property portfolio. Its operations also extend to managing intellectual property and engaging in the medical supply and procurement sector. Established in 1983, the company's headquarters are located in Stellenbosch, South Africa.
Aktienkurs
$6.02
Zuletzt synchronisiert: 2023-05-26
Marktkapitalisierung
$3.60B
Veränderung (1 Tag)
-18.50%
Veränderung (1 Jahr)
0.00%
Land
ZA
Handel Mediclinic International plc (MEI)
Kategorie
Healthcare
Gewinn für Mediclinic International plc (MEI)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Mediclinic International plc betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Mediclinic International plc von 2002 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2022 | $277.39M | 93.49% |
| 2021 | $143.36M | -142.02% |
| 2020 | $-341.20M | 91.25% |
| 2019 | $-178.40M | -73.43% |
| 2018 | $-671.37M | -274.32% |
| 2017 | $385.13M | 9.40% |
| 2016 | $352.04M | -9.94% |
| 2015 | $390.90M | -5.08% |
| 2014 | $411.82M | -1,364.13% |
| 2013 | $-32.58M | -111.54% |
| 2012 | $282.38M | -5.17% |
| 2011 | $297.78M | 31.08% |
| 2010 | $227.17M | 77.70% |
| 2009 | $127.84M | -4.36% |
| 2008 | $133.66M | 1.05% |
| 2007 | $132.28M | -5.47% |
| 2006 | $139.93M | 7.47% |
| 2005 | $130.20M | 26.17% |
| 2004 | $103.20M | 51.14% |
| 2003 | $68.28M | 68.21% |
| 2002 | $40.59M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $9.87B | - |
US
|
|
| - | - |
DE
|
|
| $3.87B | - |
US
|
|
| $687.82M | - |
SA
|
|
| $1.25B | - |
BR
|
